IGF2BP2 and acute myeloid leukemia: IGF2BP2 enhances the stability of MYC, SLC1A5, and GPT2 mRNA in an m6A‐dependent manner, promoting their translation and maintaining LSC/LIC function, thus accelerating AML progression.263